1. Home
  2. KRMD vs STXS Comparison

KRMD vs STXS Comparison

Compare KRMD & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

N/A

Current Price

$3.16

Market Cap

192.5M

Sector

Health Care

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.32

Market Cap

139.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRMD
STXS
Founded
1980
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.5M
139.3M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
KRMD
STXS
Price
$3.16
$1.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$6.50
$4.00
AVG Volume (30 Days)
163.0K
486.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
16.67
EPS
N/A
N/A
Revenue
$41,127,366.00
$29,346,617.00
Revenue This Year
$20.32
$28.22
Revenue Next Year
$17.37
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$3.12
$1.24
52 Week High
$6.61
$3.59

Technical Indicators

Market Signals
Indicator
KRMD
STXS
Relative Strength Index (RSI) 32.54 40.91
Support Level N/A $1.30
Resistance Level $3.43 $1.51
Average True Range (ATR) 0.10 0.06
MACD 0.02 -0.00
Stochastic Oscillator 20.59 22.45

Price Performance

Historical Comparison
KRMD
STXS

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: